Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trialsRobert E. Shapiro, Amaal J. Starling, Erin Doty et al.|The Journal of Headache and Pain|2019Cited by 88
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive reviewEdoardo Caronna, Patricia Pozo‐Rosich, Thomas C. van den Hoek et al.|Cephalalgia|2023Cited by 55